We would like to thank Drs Lowenthal, Shah, and Bernstein for their interest in our study. 1 We agree that there is emerging evidence that serum brain natriuretic peptide (BNP) levels may be lower in patients with single-ventricle physiology compared with those with biventricular physiology. 2, 3 In the Pediatric Carvedilol Trial, patients were classified as having congenital heart disease or cardiomyopathy, and ventricular morphology was characterized by the echocardiography core laboratory as a systemic left ventricle (LV) or a systemic non-LV. No further anatomic information was collected; thus, it was not possible to compare BNP levels between patients with singleventricle physiology and those with biventricular hearts. The median BNP levels at enrollment were not different for subjects with a systemic non-LV compared with those with a systemic LV (108 pg/mL and 113 pg/mL, respectively, Pϭ0.95). The small number of patients with a systemic non-LV (nϭ37) precluded meaningful analysis to determine the predictive value of the enrollment BNP level for worse outcome in this subgroup.
